B+
Bull case
25%
Probability
Target price
$110.00
+84.9% vs current
COO
Cooper CompaniesCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$90.56
+52.2% vs current
B-
Bear case
15%
Probability
Target price
$65.00
+9.3% vs current
AI sentiment snapshot
Latest data as of 2026-03-07
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Market tone is cautiously constructive: recent target raises and an analyst median above the anchor support upside expectations [#SERP-3]. Short-term views remain mixed due to a wide spread in analyst targets and sensitivity to upcoming earnings and any clinical/regulatory news [#SERP-1].
RankAlpha Sentiment AI - 2026-03-07
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-06-05eventNext quarterly earnings release and guidanceHigh impact
Quarterly results and management guidance can reprice the stock; recent analyst notes and target updates signal market attention. Date not disclosed publicly; conservative assumed date used (see assumption) [#SERP-3], [#SERP-1]. Assumption: expected_date is estimated as the conservative window end.
2026-06-05catalystAnalyst target revisions and consensus momentumHigh impact
Multiple recent target updates and consensus reporting (average/median near $90–92) may drive short-term upward revisions or volatility as analysts publish notes [#SERP-3], [#SERP-2].
2027-03-07catalystContact-lens market share gains and product cycleHigh impact
Sustained adoption of new products and geographic/segment expansion could drive multi-quarter upside; market commentary and consensus targets imply upside over the next year [#SERP-1], [#SERP-9].
Recommendation
N/A
No formal recommendation provided.
As of 2026-03-07 • Updated nightlySource: Internal modelMethodology